Revenue | ₹17.73Cr |
Net Profits | ₹0.50Cr |
Net Profit Margins | 2.82% |
Sandu Pharmaceuticals Ltd’s revenue jumped 6.23% since last year same period to ₹17.73Cr in the Q2 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 3.74% jump in its revenue since last 3-months.
Sandu Pharmaceuticals Ltd’s net profit fell -9.09% since last year same period to ₹0.50Cr in the Q2 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 194.12% jump in its net profits since last 3-months.
Sandu Pharmaceuticals Ltd’s net profit margin fell -14.42% since last year same period to 2.82% in the Q2 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 183.5% jump in its net profit margins since last 3-months.
The revenue for Sandu Pharmaceuticals Ltd in the Q2 results 2024 was ₹17.73Cr.
The net profit for Sandu Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.50Cr.
The net profit margin for Sandu Pharmaceuticals Ltd in the Q2 results 2024 was 2.82%.
The revenue for Sandu Pharmaceuticals Ltd in the Q2 results 2023 was ₹16.69Cr.
The net profit for Sandu Pharmaceuticals Ltd in the Q2 results 2023 was ₹0.55Cr.
The net profit margin for Sandu Pharmaceuticals Ltd in the Q2 results 2023 was 3.30%.